BNP PARIBAS EASY ECPI Global ESG Med TechBNP PARIBAS EASY ECPI Global ESG Med TechBNP PARIBAS EASY ECPI Global ESG Med Tech

BNP PARIBAS EASY ECPI Global ESG Med Tech

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪1.24 M‬EUR
Fund flows (1Y)
‪−12.20 M‬EUR
Dividend yield (indicated)
Discount/Premium to NAV
−0.04%
Shares outstanding
‪153.33 K‬
Expense ratio
0.32%

About BNP PARIBAS EASY ECPI Global ESG Med Tech


Brand
BNP Paribas
Inception date
Dec 10, 2021
Structure
Luxembourg SICAV
Index tracked
ECPI Global ESG Medical Tech Index - EUR - Benchmark TR Net
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
BNP PARIBAS ASSET MANAGEMENT Luxembourg SA
ISIN
LU2365457410
Replicate the performance of the ECPI Global ESG Medical Tech (NR) Index (Bloomberg: GALPHMTN Index), including fluctuations, and to maintain the Tracking Err between the sub-fund and the index below 1%.

Classification


Asset Class
Equity
Category
Size and style
Focus
Total market
Niche
Broad-based
Strategy
Multi-factor
Geography
Global
Weighting scheme
Multi-factor
Selection criteria
Multi-factor

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of June 17, 2025
Exposure type
Stocks
Health Technology
Stocks100.00%
Health Technology94.60%
Commercial Services2.77%
Technology Services2.63%
Bonds, Cash & Other0.00%
Stock breakdown by region
5%42%45%5%
Europe45.76%
North America42.85%
Oceania5.85%
Asia5.54%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


EGEMT invests in stocks. The fund's major sectors are Health Technology, with 94.60% stocks, and Commercial Services, with 2.77% of the basket. The assets are mostly located in the Europe region.
EGEMT top holdings are BeOne Medicines Ltd. and Eurofins Scientific SE, occupying 2.88% and 2.77% of the portfolio correspondingly.
EGEMT assets under management is ‪1.24 M‬ EUR. It's fallen 1.20% over the last month.
EGEMT fund flows account for ‪−12.20 M‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, EGEMT doesn't pay dividends to its holders.
EGEMT shares are issued by BNP Paribas SA under the brand BNP Paribas. The ETF was launched on Dec 10, 2021, and its management style is Passive.
EGEMT expense ratio is 0.32% meaning you'd have to pay 0.32% of your investment to help manage the fund.
EGEMT follows the ECPI Global ESG Medical Tech Index - EUR - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
EGEMT invests in stocks.
EGEMT price has fallen by −1.78% over the last month, and its yearly performance shows a −6.18% decrease. See more dynamics on EGEMT price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −2.51% over the last month, showed a −6.43% decrease in three-month performance and has decreased by −5.60% in a year.
EGEMT trades at a premium (0.04%) meaning the ETF is trading at a higher price than the calculated NAV.